By their very nature, specialties are designed so physicians can focus their knowledge base and skill set on certain areas of the extremely broad and deep field of medicine. But the specialty of neurology itself is becoming increasingly complex, with disease states that vary widely and are treated quite differently, including the patient’s medication regime.
We know that the U.S. has a growing shortage of physicians that’s reaching crisis proportions. The shortage is estimated at between 42,600 and 121,300 physicians by 2030, especially in primary care, the specialty that drives patient-centered care in most models. The advantages of team-based care become even more compelling when viewed in this light.
The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease updates evaluations and recommendations based on the class of risk (COR) and level of evidence (LOE) for the prevention of atherosclerotic cardiovascular disease (ASCVD). Here’s the low-down on low-dose aspirin.
Taking a BZD in combination with an opioid increases the risk of a drug overdose 10 times and increases the risk of overdose in a dose-dependent fashion.
Whether it’s weed, edibles, salves or oils, legally available marijuana-based products used as medication continues to be — pun intended — on the rise. With an aging population with multiple and often chronic conditions, it’s no huge surprise. Thus, the importance of taking its growing availability seriously shouldn’t be overlooked when considering all aspects of a patient’s medication regimen and its ongoing management.
With continued expansion of the recalls for various angiotensin II receptor blockers (ARBs), many patients, pharmacists and prescribers are left seeking guidance. Various products containing irbesartan, losartan and valsartan — all ARBs — have been affected by the recall. We’re here to help.